Cargando…
Pulmonary metastasectomy in colorectal cancer: A letter in response to Antonoff and colleagues
Autores principales: | Macbeth, Fergus, Dunning, Joel, Treasure, Tom |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9390400/ https://www.ncbi.nlm.nih.gov/pubmed/36004202 http://dx.doi.org/10.1016/j.xjon.2021.08.031 |
Ejemplares similares
-
Pulmonary metastasectomy: limits to credibility
por: Treasure, Tom, et al.
Publicado: (2021) -
Reply from author: What is the right answer for pulmonary metastatic disease? More clinical trials
por: Antonoff, Mara B.
Publicado: (2021) -
Reply: We all look for high evidence levels
por: Kesler, Kenneth A.
Publicado: (2021) -
Comment on: ‘KRAS and BRAF mutations are prognostic biomarkers in patients undergoing lung metastasectomy of colorectal cancer.' Variation in survival associated with proto-oncongenes is not evidence for effectiveness of lung metastasectomy
por: Cardillo, Giuseppe, et al.
Publicado: (2015) -
The full cohort of 512 patients and the nested controlled trial in 93 patients in the Pulmonary Metastasectomy in Colorectal Cancer (PulMiCC) study raise doubts about the effective size at present claimed
por: Treasure, Tom, et al.
Publicado: (2022)